The Utility of MRI Scoring to Predict Neurodevelopmental Outcomes in Survivors of Twin-to-Twin Transfusion Syndrome
CompletedOBSERVATIONAL
Enrollment
51
Participants
Timeline
Start Date
September 30, 2014
Primary Completion Date
September 30, 2020
Study Completion Date
May 30, 2024
Conditions
Fetofetal Transfusion
Trial Locations (1)
63104
Cardinal Glennon Children's Medical Center, St Louis
All Listed Sponsors
collaborator
St. Louis University
OTHER
lead
Catherine Cibulskis, MD
OTHER
NCT02249624 - The Utility of MRI Scoring to Predict Neurodevelopmental Outcomes in Survivors of Twin-to-Twin Transfusion Syndrome | Biotech Hunter | Biotech Hunter